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Abstract:
Background: Epidemiological data show that colorectal cancer (CRC) is the second 
most  frequent  malignancy worldwide.  The involvement  of  “minor  impact  genes” such as 
XME and DNA-repair genes in the etiology of sporadic cancer has been postulated by other 
authors. 
Aim: we focused on analyzing polymorphisms in DNA-repair genes in CRC. We 
considered  the  following  genes  involved  in  DNA-repair  pathways:  base  excision  repair 
(OGG1 Ser326Cys, XRCC1 Trp194Arg and Arg399Gln); nucleotide excision repair   [XPA  (-
4)G/A,  XPC C/A  (i11)  and  A33512C  (Lys939Gln), XPD Asp312Asn  and  A18911C 
(Lys751Gln),  XPF  Arg415Gln,  XPG Asp1104His,  ERCC1 C118T];  homologous 
recombination repair [ NBS1 Glu185Gln, Rad51 135G/C, XRCC3 C18067 (Thr241Met)]. 
Material  and  methods:  The  study  group consisted  of  133 patients  diagnosed with 
sporadic  CRC,  while  the  control  group  was  composed  of  100  age-matched  non-cancer 
volunteers. Genotyping was performed by PCR and PCR-RFLP.  Fisher’s exact test with a 
Bonferroni correction for multiple testing was used. 
Results:  We found that:  i) XPC C/A (i11)  heterozygous variant  is  associated  with 
increased risk of  CRC [OR is  2.07 (95% CI 1.1391,3.7782) p=0.038],  ii) XPD A18911C 
(Lys751Gln) is associated with decreased risk of CRC [OR=0.4497, (95% CI 0.2215,0,9131) 
p=0.031] for an individual with at least one A allele at this locus.
Conclusions:
1. the  XPC C/A (i11) genotype  is associated with an increased risk of sporadic colorectal 
cancer. 
2. the NER pathway has been highlighted in our study, as a most important in modulation of  
individual susceptibility to sCRC. 
1. Introduction:
Despite great progress in our knowledge regarding the development and treatment of 
cancer, sporadic colorectal cancer (sCRC) still remains one of the most common cancers and 
the cause of a high proportion of cancer-related deaths in developed countries [1,2]. There is a 
growing body of evidence that an individual’s susceptibility to sCRC depends on both his/her 
an individual’s genetic profile (so called “genetic makeup”) and exposure to exogenous and 
endogenous carcinogens (DNA damaging agents) [3,4]. 
The risk of sporadic CRC is modified mainly (approximately 80%) by environmental 
and lifestyle  factors that could  be a  source of DNA-damaging carcinogens [6].  Thus,  the 
capacity for DNA-repair, determined by the polymorphisms in DNA-repair genes, seems to be 
essential  in  ensuring  genomic  (molecular  and  chromosomal)  stability,  which  in  turn  is 
strongly associated with the risk of sCRC. DNA-repair genes act on a variety of pathways 
depending on the type of DNA-damage. The base excision repair (BER) pathway is involved 
mainly in the removal of oxidative DNA damage induced by reactive oxygen species [5]. The 
8-oxoguanine DNA glycosyslase (OGG1) gene encodes a DNA repair protein that removes 8-
oxo-7,8-dihydroguanine (8-oxoG) [6]. The variant allele of the Ser326Cys polymorphism is 
associated  with  higher  level  of  genetic  instability  and  seems  to  be  associated  with  an 
increased  risk  of  lung,  esophagus,  prostate  cancer  as  well  as  ALL (acute  lymphoblastic 
leukemia) among children [7-9].  Opinion is  divided as to whether there is  an association 
between OGG1,  Ser326Cys  and colorectal  cancer  [8,10,11].  The  XRCC1 gene  encodes  a 
protein that interacts with other DNA-repair proteins, such as Lig3, Polβ and PARP, creating a 
complex involved in short-patch BER [6]. Two polymorphisms: Arg194Trp and Arg399Gln 
have  been  widely  studied  in  cancer  epidemiology.  It  has  been  proven  that  Arg194Arg 
individuals have a  higher  level  of DNA damage compared to  those with one or  two Trp 
variant  alleles,  while  the  highest  level  of  DNA  damage  is  observed  in  Gln399Gln 
homozygotes  [12].  The 194Trp variant  has  also been found to be protective  against  lung 
cancer,  although  it  is  associated  with  an  increased  risk  of  CRC [8].  The  results  for  the 
Arg399Gln polymorphism of the  XRCC1 gene in colorectal  cancer epidemiology are very 
ambiguous [13-18]. 
Nucleotide excision repair (NER) is involved in the removal of DNA thymidyne 
dimmers  and  bulky  adducts,  induced  by  UV  light,  tobacco  smoke  and  environmental 
xenobiotics  [19].  The  NER  pathway  consists  of  about  30  genes  called  Xeroderma 
Pigmentosum (XP) or the excision repair cross-complementing group (ERCC). The XPA (-4) 
G/A variant localized in Kozak sequence near the ATG-start codon may influence the level of 
the XPA protein [20]. The presence of at least one G-allele is associated with a decreased risk 
of lung cancer in Caucasians, Koreans and Americans [21]. Nevertheless, Hansen et al. did 
not observe any statistically significant interaction between this polymorphism and the risk of 
CRC [22]. 
The XPC protein is involved in the XPC-HR23B DNA-damage-recognition complex 
of GG-NER [19].  Three polymorphisms in  XPC [A33512C in exon 15 (Lys939Gln)],  the 
insertion/deletion poly AT (PAT) in intron 9 and the C/A polymorphism in intron 11 are in  
high linkage disequilibrium [23]. The XPC PAT+/+ variant was shown to be associated with 
reduced capacity for DNA repair and an increased risk of lung cancer [23,24]. The variant 
allele of the  XPC  exon 15 polymorphism has been found to be associated with the risk of 
bladder cancer [25]. The XPD gene encodes the helicase participating in the transcription 
factor IIH. The 312Asn and 751Gln variant alleles of XPD correlate with a reduced capacity 
for repairing bulky adducts [12]. However, the results of studies on XPD polymorphisms with 
regard to a variety of human cancers remain contradictory [22,26,27]. The XPF gene encodes 
a protein which, together with ERCC1, creates the 5’endonuclease [28]. The results of studies 
on XPF and ERCC1 variants and the risk of cancer are also contradictory. [29-31]. The XPG 
gene  encodes  the  3’ endonuclease  of  the  NER  pathway.  The  wild  type  allele  of  XPG 
(Asp1104His) has been shown to be associated with a decreased risk of lung cancer especially 
among  light  smokers  and  non-smokers  [32].  There  is  a  lack  of  available  data  on 
polymorphisms of the XPF and XPG genes and the risk of sCRC.
Homologous recombination repair (HR) is involved in the repair of double strand 
breaks (DSBs) [30]. The NBS1 (Nibrin) protein is a component of the MRN-complex, which 
recognizes DSBs [31]. Most studies investigating the NBS1 Glu185Gln polymorphism have 
focused on assessing the risk of breast cancer [32]. There is only one publication on this 
NBS1 polymorphism and risk of colorectal cancer [33]. The XRCC3 protein interacts with 
Rad51-related  proteins  in  the  process  of  homologous  recombination.  The  C18067T 
(Thr241Met) variant of the XRCC3 gene in exon 7 modulates its function and is linked to an 
increased risk of  bladder,  breast,  colorectal,  lung and skin cancer  [37-41].  Rad51 plays  a 
crucial  role  in  the HR pathway.  The increased risk of endometrial  cancer  for  the G135C 
variant of Rad51 have been shown as well as for breast cancer among carriers of the BRCA1 
mutation [42,43]. Recently it has been postulated that the above mentioned polymorphism of 
the Rad51 gene could be an independent marker of colorectal cancer risk [44].
We aimed to find polymorphisms of the chosen DNA-repair genes which modulate 
the  risk  of  sCRC.  We  focused  on  the  following  genes:  1)  OGG1  Ser326Cys,  XRCC1 
Trp194Arg  and  Arg399Gln  (BER),  2)  XPA  (-4)G/A,  XPC C/A  (i11)  and  A33512C 
(Lys939Gln), XPD Asp312Asn  and  A18911C (Lys751Gln),  XPF  Arg415Gln,  XPG 
Asp1104His,  ERCC1 C118T (NER), 3)  NBS1 Glu185Gln,  Rad51 G135C,  XRCC3 C18067T 
(Thr241Met) (HR). 
2. Materials and methods
2.1 Patients and controls
The study and the control group consisted entirely of Polish individuals (all Caucasi-
ans), who came from the same geographic area (Lower Silesia). The study group consisted of 
133 patients diagnosed with sporadic colorectal adenocarcinoma (sCRC). The mean age of the 
patients was 63.22 with a standard deviation of 11.36. Blood samples from the study group 
were collected from the 2nd Department of General and Oncological Surgery, Wroclaw Med-
ical University and the Department of General Surgery, Regional Specialized Hospital, Wro-
claw. 
The control group consisted of 100 patients of the Department of Internal Diseases, 
Clinical Hospital, Swiebodzice, Poland. Their mean age was 74.89 with a standard deviation 
of 7.63. We decided to compose the control group of individuals approximately 15 years older 
on average than the cancer patients, because the risk of sCRC cancer is age-related. None of 
the control group suffered from cancer or had a family history of cancer.
The design of the study was accepted by the Wroclaw Medical University Ethics Committee 
and each of individual signed informed consent.
2.2 Analysis of the polymorphisms 
Genomic  DNA  was  isolated  from  peripheral  blood  lymphocytes  using  standard 
phenol-chloroform  extraction  and  ethanol  precipitation.  The  analyses  of  14  SNPs  in  the 
following DNA-repair genes: OGG1, XRCC1, XPA, XPC, XPD, XPF, XPG, ERCC1, XRCC3,  
Rad 51 and NBS1, were carried out using a polymerase chain reaction and restriction fragment 
length polymorphism (PCR-RFLP) assays as we have previously described [45]. To genotype 
OGG1 Ser326Cys, we employed the method of Le Marchand et al. [46]. The final products 
were analyzed using gel electrophoresis on a 2% agarose gel stained with ethidium bromide 
and visualized directly under UV light. 
2.3 Statistical analysis
The chi-squared goodness of fit test was used to test whether the genotype frequencies 
corresponded  to  the  Hardy-Weinberg  equilibrium  and  to  test  for  linkage  disequilibrium 
between  pairs  of  loci.  The  frequencies  of  extended  haplotypes  were  estimated  using  an 
iterative procedure based on a standard gene counting procedure [47].
Fisher’s exact test was used to assess differences in phenotype distribution between 
the two groups, firstly under the assumption that the non-wild type allele (assumed to be the 
least frequent allele) is dominant and secondly under the assumption that the non-wild type 
allele is recessive [48]. Logistic regression was used to derive of model for the likelihood of 
developing CRC given the genetic data. Statistical tests were performed using the SPSS and R 
software packages.  
3. Results
We have determined the frequencies of 14 SNPs in 11 genes involved in three DNA 
repair pathways in sCRC patients compared to the control group. In the first step the loci were 
tested for agreement with the Hardy-Weinberg equilibrium and linkage disequilibrium.
The OGG1, RAD51, XPF polymorphisms and the  polymorphism at codon 194 Arg/Trp of the 
XRCC1 were omitted from the analysis, since there was too little variation at these sites for  
the  approximation  used  to  be  reliable.  No significant  deviations  were  observed from the 
Hardy-Weinberg  equilibrium  in  the  control  group.  Significant  deviations  from  this 
equilibrium were found in the study group at the following loci:  XPC intron 11 (p<0.001), 
ERCC1 C118T (p<0.01) and XPG Asp1104His (p<0.05). In the case of  XPC intron 11, this 
result is significant at the 1% level, even when the Bonferroni correction is taken into account 
(based on the 10 sites considered). In both the sCRC-patient and control groups a significant 
level  of  linkage  disequilibrium  was  observed  for  two  pairs  of  polymorphisms  i)  XPC 
A33512C  (Lys939Gln)  and  XPC  C/A (i11)  (p<0.01  after  the  application  of  Bonferroni 
correction);  ii)  XPD  Asp312Asn  and  XPD A18911C (Lys751Gln)  (p<0.001  after  the 
application of Bonferroni correction).
The analysis of association between polymorphisms in a single gene and sCRC revealed a 
significant association between the  XPC C/A (i11) locus and sCRC risk (recessive model, 
p=0.038).  The odds of  a  heterozygote  with an  A allele  at  this  locus developing sCRC is 
estimated  to  be  2.07  times  the  odds  for  an  individual  with  a  C/C  genotype.  The  95% 
confidence interval for this odds ratio is [1.1391,3.7782]. Moreover, individuals with an A/A 
were not significantly more likely to develop sCRC. 
There  was  also  a  significant  association  between  the  XPD A18911C (Lys751Gln) 
polymorphism and the risk of sCRC (dominant model, p=0.031). The odds of an individual 
with a C/C (A18911C) genotype developing sCRC is estimated to be 0.4497 times the odds 
for an individual with at least one A allele at this locus. The 95% confidence interval for this 
odds ratio is [0.2215,0.9131] (see Table 1). No other associations were observed (see Table 2, 
available online).
We also investigated the association between an individual’s genotype based on a pair of loci 
and the risk of developing sCRC. A significant association was found for the following seven 
pairs of loci: 1) XRCC3 C18067T (Thr241Met)/RAD51 G135C (p=0.01691, here due to their 
small  number  135C/135C  individuals  were  grouped  with  135C/wt  individuals),  2) XPG 
Asp1104His/ERCC1 C118T (p=0.04297),  3) XPF Arg415Gln/XPC A33512C (Lys939Gln) 
(p=0.01009),  4) XPC in(11)/XPC A33512C  (Lys939Gln)  (p=0.009246),  5) XPC 
in(11)/ERCC1 C118T (p=0.04390),  6) XPC in(11)/XPF Arg415Gln  (p=0.01691),  7) XPD 
Asp312Asn/XPD A18911C (Lys751Gln)  (p=0.03596).  Several  models  based  on  logistic 
regression were considered. In each case, factors were sequentially added to the model until 
no factor outside the model was significant. The first model considered sex and all the loci as 
possible factors. This model stated that taking into account sex (males are more susceptible),  
individuals with an A allele at  XPC (i11) are more susceptible to sCRC (p=0.013). In the 
second model considered, sex, the XPC (i11) locus and the XPD A18911C (Lys751Gln) were 
treated as possible factors, together with the genotypes based on the following three pairs of 
loci not including the two loci above 1)  XRCC3 C18067T (Thr241Met)/RAD51 G/135C, 2) 
XPG  Asp1104His/ERCC1 C118T and 3)  XPF Arg415Gln/XPC A33512C (Lys939Gln) (the 
most frequent double homozygote was used as a baseline for comparison in each case). Apart 
from the significant effect of  XPC (i11) found in the previous model, this model found the 
following associations: XPF Arg415Gln/XPC A33512C (Lys939Gln) – double heterozygotes 
have a higher susceptibility to sCRC than Arg415Arg/A33512A (Lys939Lys) (the “wild-type” 
double  homozygote,  p<0.01).  XRCC3  C18067T (Thr241Met)/RAD51 G135C–  CC 
(18067)/G135C  individuals  are  more  susceptible  than  CC  (18067)/G135G  individuals 
(p<0.05).  XPG  Asp1104His/ERCC1 C118T – GG/CT, GC/TT and CC/CT individuals  are 
more susceptible to CRC that GG/TT individuals (p<0.05, p<0.05 and p<0.01, respectively). 
Due to the relatively low frequency of some of the genotypes, it is difficult to make strong 
conclusions based on these results. However, one interesting aspect is that for the three pairs 
considered in the analysis, double homozygotes showed a low level of susceptibility to sCRC.
4. Discussion
The complexity  of  the  process  of  carcinogenesis,  has  led  to  a  situation  in  which, 
despite  tremendous  research  effort,  the  genetic  etiology  of  sporadic  cancers  still  remains 
largely uncovered. Yet the understanding of this complexity resulted in the multi-hit theory of 
cancer [46], which seems to be more comprehensive with sporadic cancers than double-hit 
theory, which in turn seems to be more comprehensive with the etiology of hereditary cancers.  
Finally, an enormous number of papers focusing on associations between the risk of cancer 
and  a  variety  of  polymorphisms/mutations  in  DNA-repair  genes  have  been  published 
(frequently presenting conflicting results). 
In  the current study, among the 14 variants in 11 DNA-repair genes analyzed, only 
variants of two genes:  XPC C/A(i11) and  XPD  A18911C (Lys751Gln)  were shown to be 
associated  with  sCRC risk.  The  carriers  of  the  homozygous C/C  A18911C (Lys751Gln) 
genotype  at  the  XPD gene  were  at  decreased  (OR 0.4497  CI  95%  0.22  -  0.91),  while 
individuals carrying C/A polymorphism in intron 11 at  XPC gene at increased  (OR 2.07 CI 
95% 1.13 -3.77) risk of sCRC. 
Previously published data focusing on the role of XPD variants in the modulation of an 
individual’s risk of developing various cancers, are scarce and often ambiguous. For example, 
the results of the study of Skjelbred CF  et al. studies on Norwegian cohort suggested that 
XPD A18911C (Lys751Gln)  variant  is  associated  with  an  increased  risk  of  low-risk 
adenomas,  but not  carcinomas [15],  while  Hansen’s  RD  et  al.  studies  on 160,725 Danish 
individuals revealed that the XPD A18911C (Lys751Gln) variant is not of a major importance 
in colorectal carcinogenesis [22]. Results similar to those of Hansen et al. [22] were recently 
published by ref.27 for Polish population Thus, the role of mentioned polymorphism of XPD 
in colorectal carcinogenesis seems to be still uncovered. 
However,  the  data  highlighting  the  role  of  XPC C/A (i11)  in  modulation  of  an 
individual risk of developing cancers, seems to be much more comprehensive. 
The meta-analysis, carried out by Zhang et al. as well as Qiu et al. revealed that XPC 
is one of the most important genes modulating an individual’s risk of developing sporadic 
cancer  [48,50].  Moreover,  recent  data  on  structure-function  relations  of  the  XPC protein 
suggest  that  even a  single  amino acid  alteration  could be sufficient  to  compromise  XPC 
function profoundly [51]. The results of our studies showing that XPC C/A (i11) individuals 
are at increased risk of sCRC are in agreement with these observations. An important role of 
XPC C/A (i11) in carcinogenesis probably results from the fact that the XPC intron 11 splice 
acceptor site polymorphism is related to an increased frequency of exon 12 skipping, leading 
thus  to  diminished DNA repair.  Khan et  al.  reported that  the homozygous variant  A/A is 
associated with an approximately 50% reduction in DNA repair capacity (DRC) of the XPC 
protein [52]. This is consistent with the observations by Lopez-Cima et al., who found that the 
PAT+/33512C(939Gln) /intron11A haplotype contributed to reduced DNA repair capacity and 
thus, to an increased risk of lung cancer [53]. 
In  the current study we did not observe any increased risk of CRC to be associated 
with the homozygous variant (A/A) in intron 11 of XPC gene. This could be explained by the 
‘greater apoptosis’ hypothesis,  stating that adverse variants with lower DRCs may have a 
greater protective effect by increasing apoptosis rate. In fact, the results of our study are in 
agreement  with  the  results  of  Huang  et  al.,  who  found  an  association  between  3 
polymorphisms  of  the  XPC gene  (492R,  499A and  33512C)  and  the  risk  of  colorectal 
adenoma,  especially  in  smokers  [54].  Tobacco  carcinogens  (like  polycyclic  aromatic 
hydrocarbons)  may cause a  DNA damage,  while  the XPC protein  plays  a  crucial  role  in 
repairing of this type of damage [54]. 
The studies of Garcia-Closas et al. and Shen et al. revealed an association between the 
risk of cancer and a single  XPC polymorphism, namely: between 33512C and the risk of 
bladder cancer, as well as the PAT+ polymorphism in intron 9 and the risk of squamous cell  
carcinoma of head and neck [55,56]. However, taking into account the high LD between these 
XPC variants, it remains to be determined whether a single polymorphism or their association 
is of most importance in the modulation of cancer risk. 
Interestingly, an  in vitro experiment has confirmed the importance of the  XPC C/A 
(i11) genotype in the preservation of genetic stability, by revealing that among young healthy 
individuals  the  XPC C/A (i11)  genotype  is  associated  with  the  frequency  of  bleomycin-
induced chromosomal aberrations (CA) [45]. This controversial observation was published by 
Kazimirova et al., who showed that C/A heterozygotes had less chromosomal aberrations than 
comparing to C/C and A/A homozygotes [57]. 
This  discrepancy  could  result  from  an  analysis  of  the  relationships  between  a 
chromosomal end-point  and a  single  genetic  variant  [57],  but  not  among a “network” of 
genetic alterations [45].
We were also searching for an association between pairs of genetic variants and CRC 
risk. Our results have revealed that NER pathway-genes were present in all but one of gene-
variant pairs, highlighted as most important in this process,. All these data taken together, 
strongly suggest the  potential role of the NER pathway (mainly of XPC), in ensuring of 
chromosomal stability and subsequently in the modulation of individual’s risk of sporadic 
colorectal cancer. 
5. Conclusions: 
On the basis of our study, in regard to relevant literature it can be stated that the XPC 
C/A (i11) is associated with an increased risk of sCRC. 
Moreover,  in spite of the fact that it is difficult to make strong conclusions based on 
the results of current studies in regard to the influence of networks of polymorphism in DNA 
repair genes on an individual’s sCRC risk by (because of the relatively low frequency of some 
of the genotypes), our results strongly supports the thesis that “it is necessary to access the  
combined effect of several polymorphisms in the same gene or between different genes that  
might contribute to cancer risk” [48]. 
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